[1] Wu Y,Song W,Su M,et al.The role of cholesterol metabolism and its regulation in tumor development[J].Cancer Med,2025,14:e70783.doi: 10.1002/cam4.70783. [2] Barbhuiya PA,Yoshitomi R,Pathak MP.Understanding the link between sterol regulatory element binding protein(SREBPs)and metabolic dysfunction associated steatotic liver disease(MASLD)[J].Curr Obes Rep,2025,14:36.doi: 10.1007/s13679-025-00626-y. [3] Bergentall M,Tremaroli V,Sun C,et al.Gut microbiota mediates SREBP-1c-driven hepatic lipogenesis and steatosis in response to zero-fat high-sucrose diet[J].Mol Metab,2025,97:102162.doi: 10.1016/j.molmet. [4] Stachowicz A,Czepiel K,Wiśniewska A,et al.Mitochon-dria-targeted hydrogen sulfide donor reduces fatty liver and obesity in mice fed a high fat diet by inhibiting de novo lipogenesis and inflammation via mTOR/SREBP-1 and NF-κB signaling pathways[J].Pharmacol Res,2024,209:107428.doi: 10.1016/j.phrs.2024.107428. [5] Ouyang N,Gan H,He Q,et al.Dysfunction of cholesterol sensor SCAP promotes inflammation activation in THP-1 macrophages[J].Exp Cell Res,2018,367:162-169. [6] Lee JH, Lee SH, Lee EH,et al.SCAP deficiency facilitates obesity and insulin resistance through shifting adipose tissue macrophage polarization[J].J Adv Res,2023,45:1-13. [7] Zhang X,Liu J.Regulating lipid metabolism in gout:a new perspective with therapeutic potential[J].Int J Gen Med,2024,17:5203-5217. [8] Kawamura S,Matsushita Y,Kurosaki S,et al.Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis[J].J Clin Invest,2022,132:e151895.doi: 10.1172/JCI151895. [9] 黄艳,袁放.不同年龄段痛风发生代谢相关脂肪性肝病的影响因素研究[J].现代医药卫生,2025,41:65-67. [10] Chen B,Bao R,Pan J,et al.Taurine alleviates dysfunction of cholesterol metabolism under hyperuricemia by inhibiting A2AR-SREBP-2/CREB/HMGCR axis[J].J Lipid Res,2025,66:100746. doi: 10.1016/j.jlr.2025.100746. [11] Zhou R,Stouffer GA,Frishman WH.Cholesterol paradigm and beyond in atherosclerotic cardiovascular disease:cholesterol,sterol regulatory element-binding protein,inflammation,and vascular cell mobilization in vasculopathy[J].Cardiol Rev,2022,30:267-273. [12] Chen Z,Martin M,Li Z,et al.Endothelial dysfunction:the role of sterol regulatory element-binding protein-induced NOD-like receptor family pyrin domain-containing protein 3 inflammasome in atherosclerosis[J].Curr Opin Lipidol,2014,25:339-349. [13] Zhao Z,Zhao Y,Zhang Y,et al.Gout-induced endothelial impairment:The role of SREBP2 transactivation of YAP[J].FASEB J,2021,35:e21613.doi: 10.1096/fj.202100337R. [14] Cheng Y,Manabe I,Hayakawa S,et al.Caspase-11 contributes to site-1 protease cleavage and SREBP1 activation in the inflammatory response of macrophages[J].Front Immunol,2023,14:1009973.doi: 10.3389/fimmu.2023.1009973. [15] Kusnadi A,Park S H,Yuan R,et al.The cytokine TNF promotes transcription factor SREBP activity and binding to Inflammatory genes to activate macrophages and limit tissue repair[J].Immunity,2019,51:241-257. [16] Moretti J,Jia B,Hutchins Z,et al.Caspase-11 interaction with NLRP3 potentiates the noncanonical activation of the NLRP3 inflammasome[J].Nat Immunol,2022,23:705-717. [17] Luo W,Adamska J Z,Li C,et al.SREBP signaling is essential for effective B cell responses[J].Nat Immunol,2023,24:337-348. [18] Xi Z,Shu L,Xiao L,et al.Macrophage NLRP3 inflammasome mediates the effects of sympathetic nerve on cardiac remodeling in obese rats[J].Mol Cell Endocrinol,2025,596:112417.doi: 10.1016/j.mce.2024.112417. [19] Steffen TL,Stafford JD,Samson WK,et al.Nesfatin-1 is a regulator of inflammation with implications during obesity and metabolic syndrome[J].Appetite,2024,203:107669.doi: 10.1016/j.appet.2024.107669. [20] Han N,Chang X,Yuan Z,et al.Expression and correlation analysis of silent information regulator 1(SIRT1),sterol regulatory element-binding protein-1(SREBP1),and pyroptosis factor in gestational diabetes mellitus[J].J Matern Fetal Neonatal Med,2024,37:2311809.doi:10.1080/14767058.2024.2311809. [21] Varghese JF,Patel R,Yadav UCS.Sterol regulatory element binding protein(SREBP)-1 mediates oxidized low-density lipoprotein(oxLDL)induced macrophage foam cell formation through NLRP3 inflammasome activation[J].Cell Signal,2019,53:316-326. [22] Guo C,Chi Z,Jiang D,et al.Cholesterol homeostatic regulator SCAP-SREBP2 Integrates NLRP3 Inflammasome activation and cholesterol biosynthetic signaling in macrophages[J].Immunity,2018,49:842-856. [23] Fei X,Huang J,Li F,et al.The Scap-SREBP1-S1P/S2P lipogenesis signal orchestrates the homeostasis and spatiotemporal activation of NF-kappaB[J].Cell Rep,2023,42:112586.doi: 10.1016/j.celrep.2023.112586. [24] Hao K,Jiang W,Zhou M,et al.Erratum:Targeting BRD4 prevents acute gouty arthritis by regulating pyroptosis:Erratum[J].Int J Biol Sci,2025,21:473-474. |